Dr. Banerjee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Princeton Pike
Lawrence, NJ 08648Phone+1 609-647-6606
Education & Training
St Vincent HospitalResidency, Internal Medicine, 2002 - 2004
Christian Medical College VelloreClass of 1979
Certifications & Licensure
IN State Medical License 2010 - 2025
Publications & Presentations
PubMed
- 131 citationsDeucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo...April W Armstrong, Melinda Gooderham, Richard B Warren, Kim A Papp, Bruce Strober
Journal of the American Academy of Dermatology. 2023-01-01 - 11 citationsEfficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized,...Shinichi Imafuku, Yayoi Tada, Lauren Hippeli, Subhashis Banerjee, Akimichi Morita
The Journal of Dermatology. 2023-05-01 - 235 citationsPhase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis.Kim A. Papp, Kenneth B. Gordon, Diamant Thaçi, Akimichi Morita, Melinda Gooderham
The New England Journal of Medicine. 2018-09-11
Press Mentions
Aarogya Setu Open Sources Its Android Code, Code Now Available on GitHub: Major Win for Privacy, AccountabilityMay 27th, 2020- Maui Derm 2024 and Maui Derm Caribbean: Top Stories, Interviews, and MoreMarch 5th, 2024
Professional Memberships
- Member
- Research Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
